Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Respiratory Frequency as a Marker of Physical Effort During High-Intensity Interval Training in Soccer Players.

Nicolò A, Montini M, Girardi M, Felici F, Bazzucchi I, Sacchetti M.

Int J Sports Physiol Perform. 2019 Apr 29:1-24. doi: 10.1123/ijspp.2019-0028. [Epub ahead of print]

PMID:
31034294
2.

Acromegaly is associated with increased cancer risk: a survey in Italy.

Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Ferone D, Montini M, Bondanelli M, De Menis E, Martini C, Puxeddu E, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Peraga G, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Berton A, Serban AL, Baldelli R, Fatti LM, Colao A, Arosio M; Italian Study Group of Acromegaly.

Endocr Relat Cancer. 2017 Sep;24(9):495-504. doi: 10.1530/ERC-16-0553. Epub 2017 Jul 14.

3.

High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study.

Giustina A, Mazziotti G, Cannavò S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2454-2464. doi: 10.1210/jc.2017-00142.

PMID:
28419317
4.

Neuromuscular demand in a soccer match assessed by a continuous electromyographic recording.

Montini M, Felici F, Nicolò A, Sacchetti M, Bazzucchi I.

J Sports Med Phys Fitness. 2017 Apr;57(4):345-352. doi: 10.23736/S0022-4707.16.06130-2. Epub 2016 Mar 25.

PMID:
27015101
5.

Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease.

Seravalle G, Carzaniga C, Sciortino G, Attanasio R, Fatti LM, Cozzi R, Montini M, Vitale G, Brambilla G, Cavagnini F, Mancia G, Grassi G, Scacchi M.

Clin Exp Pharmacol Physiol. 2013 May;40(5):333-7. doi: 10.1111/1440-1681.12082.

PMID:
23528035
6.

Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.

Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, Limone P, Crivellaro C, Martinelli I, Montini M, Disoteo O, Ambrosi B, Lanzi R, Arosio M, Senni S, Balestrieri A, Solaroli E, Madeo B, De Giovanni R, Strollo F, Battista R, Scorsone A, Giagulli VA, Collura D, Scillitani A, Cozzi R, Faustini-Fustini M, Pia A, Rinaldi R, Allasino B, Peraga G, Tassone F, Garofalo P, Papini E, Borretta G.

J Clin Endocrinol Metab. 2012 Oct;97(10):3467-75. doi: 10.1210/jc.2012-1323. Epub 2012 Jul 5.

7.

Predictors of morbidity and mortality in acromegaly: an Italian survey.

Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavò S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M; Italian Study Group of Acromegaly.

Eur J Endocrinol. 2012 Aug;167(2):189-98. Epub 2012 May 17.

8.

Decreased adrenergic tone in acromegaly: evidence from direct recording of muscle sympathetic nerve activity.

Seravalle G, Carzaniga C, Attanasio R, Grassi G, Lonati L, Facchini C, Cozzi R, Fatti LM, Montini M, Vitale G, Sciortino G, Damanti S, Brambilla G, Cavagnini F, Mancia G, Scacchi M.

Clin Endocrinol (Oxf). 2012 Aug;77(2):262-7. doi: 10.1111/j.1365-2265.2012.04335.x.

PMID:
22233452
9.

Caffeine improves neuromuscular function during maximal dynamic exercise.

Bazzucchi I, Felici F, Montini M, Figura F, Sacchetti M.

Muscle Nerve. 2011 Jun;43(6):839-44. doi: 10.1002/mus.21995. Epub 2011 Apr 12.

PMID:
21488053
10.

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.

Mazziotti G, Porcelli T, Bogazzi F, Bugari G, Cannavò S, Colao A, Cozzi R, De Marinis L, degli Uberti E, Grottoli S, Minuto F, Montini M, Spinello M, Giustina A.

Eur J Endocrinol. 2011 Mar;164(3):341-7. doi: 10.1530/EJE-10-0811. Epub 2011 Jan 6.

PMID:
21212103
11.

Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.

Cozzi R, Lasio G, Cardia A, Felisati G, Montini M, Attanasio R.

J Endocrinol Invest. 2009 May;32(5):460-4. doi: 10.1007/BF03346486. Epub 2009 Apr 29.

PMID:
19494715
12.

High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.

Giustina A, Bonadonna S, Bugari G, Colao A, Cozzi R, Cannavo S, de Marinis L, Degli Uberti E, Bogazzi F, Mazziotti G, Minuto F, Montini M, Ghigo E.

Eur J Endocrinol. 2009 Aug;161(2):331-8. doi: 10.1530/EJE-09-0372. Epub 2009 May 22.

PMID:
19465485
13.

Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter study.

Attanasio R, Lanzi R, Losa M, Valentini F, Grimaldi F, De Menis E, Davì MV, Battista C, Castello R, Cremonini N, Razzore P, Rosato F, Montini M, Cozzi R.

Endocr Pract. 2008 Oct;14(7):846-55.

PMID:
18996812
14.

Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients.

Attanasio R, Mainolfi A, Grimaldi F, Cozzi R, Montini M, Carzaniga C, Grottoli S, Cortesi L, Albizzi M, Testa RM, Fatti L, De Giorgio D, Scaroni C, Cavagnini F, Loli P, Pagani G, Ghigo E.

J Endocrinol Invest. 2008 Aug;31(8):704-10.

PMID:
18852531
15.

An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.

Attanasio R, Montini M, Valota M, Cortesi L, Barbò R, Biroli F, Tonnarelli G, Albizzi M, Testa RM, Pagani G.

Pituitary. 2008;11(1):1-11.

PMID:
17690987
16.

Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.

Cozzi R, Montini M, Attanasio R, Albizzi M, Lasio G, Lodrini S, Doneda P, Cortesi L, Pagani G.

J Clin Endocrinol Metab. 2006 Apr;91(4):1397-403. Epub 2006 Jan 31.

PMID:
16449332
17.

Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?

Cozzi R, Attanasio R, Grottoli S, Pagani G, Loli P, Gasco V, Pedroncelli AM, Montini M, Ghigo E.

J Endocrinol Invest. 2004 Dec;27(11):1040-7.

PMID:
15754736
18.

The effects of somatostatin analogs on tumor shrinkage in acromegaly.

Pedroncelli AM, Montini M, Albizzi M, Barbò R, Pagani G.

J Endocrinol Invest. 2003;26(8 Suppl):50-4. Review. No abstract available.

PMID:
15233213
19.

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M, Albizzi M, Dallabonzana D, Pedroncelli AM.

J Clin Endocrinol Metab. 2003 Jul;88(7):3090-8.

PMID:
12843148
20.

Diffusion model of pain language and quality of life in orofacial pain patients.

Mauro G, Tagliaferro G, Montini M, Zanolla L.

J Orofac Pain. 2001 Winter;15(1):36-46.

PMID:
11889646
21.

Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients.

Verhelst JA, Pedroncelli AM, Abs R, Montini M, Vandeweghe MV, Albani G, Maiter D, Pagani MD, Legros JJ, Gianola D, Bex M, Poppe K, Mockel J, Pagani G.

Eur J Endocrinol. 2000 Nov;143(5):577-84.

PMID:
11078980
22.

"Spontaneous" reduction of tonsillar herniation in acromegaly: a case report.

Agostinis C, Caverni L, Montini M, Pagani G, Bonaldi G.

Surg Neurol. 2000 Apr;53(4):396-9. No abstract available.

PMID:
10825527
23.

Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).

Fisker S, Kaal A, Montini M, Pedroncelli A, Pagani G, Orskov H.

Eur J Endocrinol. 1997 Jan;136(1):61-6.

PMID:
9037128
24.

Cholelithiasis and acromegaly: therapeutic strategies.

Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, Bonelli M, Lancranjan I, Pagani G.

Clin Endocrinol (Oxf). 1994 Mar;40(3):401-6.

PMID:
8187305
25.

Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients.

Pagani MD, Tengattini F, Montini M, Pagani G, Pedroncelli A, Gianola D, Gherardi F, Mazzocchi N, Cortesi L, Lancranjan I.

Clin Endocrinol (Oxf). 1992 Apr;36(4):369-74.

PMID:
1424170
26.

A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.

Gianola D, Pedroncelli A, Montini M, Tengattini F, Pagani MD, Cortesi L, Cappi MP, Gherardi F, Lancranjan I, Pagani G.

Gynecol Endocrinol. 1991 Sep;5(3):213-6.

PMID:
1776507
27.

Hypocalcemic effects of rectal and intramuscular administration of synthetic salmon calcitonin.

Pagani G, Pagani MD, Gianola D, Pedroncelli A, Cortesi L, Gherardi F, Gualteroni L, Tengattini F, Montini M.

Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):329-32.

PMID:
1743807
28.

Medical management of acromegaly: effects of SMS 201-995 in 30 patients.

Pagani G, Montini M, Gianola D, Pagani MD, Tengattini F, Dominoni P, Ghilardi G, Cortesi L, Pedroncelli A, Tonnarelli GP.

Endocrinol Exp. 1990 Mar;24(1-2):175-85.

PMID:
2361459
29.

New perspectives in medical management of hyperprolactinemia.

Montini M, Gianola D, Pagani MD, Tengattini F, Dominoni P, Sileo F, Ferrari L, Stroppa S, Gualteroni L, Pagani G.

Endocrinol Exp. 1990 Mar;24(1-2):159-66.

PMID:
2361458
30.

Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine.

Montini M, Pagani G, Gianola D, Pagani MD, Piolini R, Camboni MG.

J Endocrinol Invest. 1990 Feb;13(2):193. No abstract available.

PMID:
2329262
31.

Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.

Montini M, Pagani G, Gianola D, Pagani MD, Salmoiraghi M, Ferrari L, Lancranjan I.

J Clin Endocrinol Metab. 1986 Jul;63(1):266-8.

PMID:
3711262
32.

[Rational basis for the therapy of differentiated carcinoma of the thyroid].

Nosari I, Tidone L, Ferrari L, Montini M, Sileo F, Pagani G, Gelli D.

Recenti Prog Med. 1984 Jul-Aug;75(7-8):758-74. Review. Italian. No abstract available.

PMID:
6438737
33.

Plasmapheresis treatment of exophtalmos: benefits and hazards.

Montini M, Nosari I, Bellavita PM, Pagani G.

Int J Artif Organs. 1983 May;6(3):157. No abstract available.

PMID:
6874128
34.

[Short-term clinical trial of a clonidine-cyclothiazide combination in the treatment of arterial hypertension].

Montini M, Sileo F.

Clin Ter. 1981 Feb 28;96(4):383-92. Italian. No abstract available.

PMID:
7214861
35.

[The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].

Vailati G, Montini M, Simonutti M, Nosari I, Pagani G.

Clin Ter. 1978 May 31;85(4):361-73. Italian. No abstract available.

PMID:
668273
36.

[Controlled clinical study and clinico-psychological evaluation of a preparation with neurotrophic effects].

Montini M, Ongaro A, Simonutti M.

Clin Ter. 1977 Aug 15;82(3):243-62. Italian. No abstract available.

PMID:
334449
37.

[Effect of glycan sulfate (3GS) on carbohydrate metabolism in patients with hypertriglyceridemia].

Vailati G, Montini M, Ongaro A, Sala P, Pagani G.

Clin Ter. 1976 Jun 15;77(5):431-9. Italian. No abstract available.

PMID:
1009746
38.

[The vanishing testis syndrome. Considerations on a case].

Vailati G, Montini M, Ongaro A, Pagani G.

Minerva Med. 1976 Apr 30;67(21):1382-5. Italian.

PMID:
934495
39.

[Synthetic PH-RH as a pituitary function test in anorexia nervosa].

Vailati G, Montini M, Ongaro A, Pagani G.

Minerva Med. 1976 Apr 30;67(21):1389-93. Italian.

PMID:
778661
40.

[Controlled application of cynarin in the treatment of hyperlipemic syndrome. Observations in 60 cases].

Montini M, Levoni P, Ongaro A, Pagani G.

Arzneimittelforschung. 1975 Aug;25(8):1311-4. German.

PMID:
170949
41.

[Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test].

Vailati G, Cuttica F, Montini M, Rebba A, Pagani G.

Clin Ter. 1974 Jan 31;68(2):149-70. Italian. No abstract available.

PMID:
4596250
42.

[Various aspects of senile hyperthyroidism].

Vailati G, Montini M, Pagani G.

Minerva Med. 1973 Apr 18;64(25):1298-305. Italian. No abstract available.

PMID:
4513470
43.

Effect of glipizide on a double-meal test in diabetic patients.

Vailati G, Pagani G, Montini M, Caputo G, Sacchetti G.

Arzneimittelforschung. 1972 Nov;22(11):1888-9. No abstract available.

PMID:
4679061
44.

[Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].

Vailati G, Montini M, Pagani G, Caputo G.

Minerva Med. 1972 Oct 3;63(69):3752-7. Italian. No abstract available.

PMID:
5078667
45.

[Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate].

Montini M, Ongaro A, Pagani G.

Reumatismo. 1972 Jan-Feb;24(1):57-68. Italian. No abstract available.

PMID:
4546498
46.

[Dioxyline phosphate in the treatment of coronary insufficiency of the aged].

Pagani G, Montini M, Armani G.

Clin Ter. 1971 Nov 30;59(4):349-56. Italian. No abstract available.

PMID:
5143687
47.

[Clinical-experimental study of lysine acetylsalicylate].

Vailati G, Montini M, Bonicelli A, Pagani G.

G Clin Med. 1971 Oct;52(10):741-55. Italian. No abstract available.

PMID:
5317238
48.

[Endocrinological and neurosurgical aspects of a case of "amenorrhea-galactorrhea" syndrome of the Forbes-Albright type].

Vailati G, Cassinari V, Agazzi C, Pagani G, Montini M.

Folia Endocrinol. 1971 Oct-Dec;24(5):489-97. Italian. No abstract available.

PMID:
5172244
49.

[Forbes-Albright syndrome. (Critical review and case report)].

Vailati G, Cassinari V, Agazzi C, Pagani G, Montini M.

Riv Crit Clin Med. 1970;70(1):213-27. Italian. No abstract available.

PMID:
5535854

Supplemental Content

Loading ...
Support Center